|
Dr. Richman is Professor of Pathology and Medicine at UCSD (University of California San Diego). He is Director of the Research Center for AIDS and HIV infection at the VA San Diego Healthcare System, where the Company intends to conduct its first HIV trial for the HIV viral entry inhibitor, BlockAide/CR, during 2004. Dr. Richman is also Director of the Center for AIDS Research at UCSD. He trained as an infectious disease physician and medical virologist at Stanford, the NIH (National Institutes of Health) and Harvard before joining the faculty at UCSD in 1976. He has focused his investigations on HIV disease and pathogenesis for the past 20 years. His laboratory was the first to identify HIV drug resistance and joined two other labs in identifying latently infected CD4 cells as the obstacle to eradication of HIV with potent antiretroviral therapy. | 